Dr. Emily Stein, MDMS

Dr. Emily Stein is Interim Chief of the Endocrine Service, Director of Research of the Metabolic Bone Service and an Endocrinologist at HSS. She is also an Associate Professor of Medicine at Weill Cornell Medical College. Dr. Stein received her undergraduate degree from Yale University, where she was elected to Phi Beta Kappa and graduated Magna Cum Laude. She received her medical degree from the Albert Einstein College of Medicine where she received a Rudin Fellowship for academic excellence and was elected to Alpha Omega Alpha. She completed her internship and residency at Columbia Presbyterian Medical Center. She was a fellow in Endocrinology and Metabolism at the combined program at New York Hospital/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center. She also completed a Masters Degree in Clinical Investigation at the Cornell Graduate School. Dr. Stein is a member of the American Society of Bone and Mineral Research, and received both a Young investigator …Award and Junior Faculty Osteoporosis Research Award from this society. Her research, supported by the National Institutes of Health, American Society of Bone and Mineral Research, as well as private foundations has focused on investigating the quality of bone in patients with osteoporotic fractures, the skeletal effects of glucocorticoids, chronic kidney disease, organ transplant and bariatric surgery. She has also studied abnormalities of vitamin D metabolism in different populations. Her recent work focuses on how bone quality impacts outcomes after orthopedic surgery. Dr. Stein is leading a randomized placebo controlled clinical trial studying whether abaloparatide treatment improves outcomes after spinal fusion surgery. Dr. Stein�s clinical practice is focused on patients with osteoporosis and metabolic bone disease. Dr. Stein has also played a role in shaping evidence based clinical practice decisions in the field, serving as a member of the American Society of Bone and Mineral Research Professional Practice Committee, the International Society of Clinical Densitometry Scientific Advisory Council and the American College of Rheumatology Glucocorticoid Induced Osteoporosis Quality Measure Development Panel.